In this context, it has been observed in several types of malignancies, including HR-NB, that high levels of IL-6 and the soluble form of its receptor (sIL-6R) in the patient’s blood and BM, correlated with bad prognosis [48,49] and would support tumor growth [50]. This evidence concerns the gene IL6R and neuroblastoma.